Skip to main content
Gregory Vercellotti, MD, Oncology, Minneapolis, MN

Gregory M Vercellotti MD

Hematologic Oncology


University of Minnesota Physicians

Join to View Full Profile
  • 424 Harvard St SE# MasonicMinneapolis, MN 55455

  • Phone+1 612-625-5411

  • Fax+1 612-625-6919

Dr. Vercellotti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Hematology and Medical Oncology, 1979 - 1982
  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1976 - 1979
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1976

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1979 - 2026
  • WI State Medical License
    WI State Medical License 1977 - 1978
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Deletion of TLR4 in Townes SS Mice Prevents Microvascular Stasis in Response to Hemin, LPS and Hypoxia/Reoxygenation: Role of Inflammation
    Gregory M Vercellotti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Increased Release of Soluble MD-2 in Sickle Cell Disease and Its Role in Pro-Inflammatory Signaling in Endothelial Cells
    Gregory M Vercellotti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Preliminary Results of a Phase 1/2 Clinical Study of Zinc Finger Nuclease-Mediated Editing of BCL11A in Autologous Hematopoietic Stem Cells for Transfusion-Dependent B...
    Gregory M Vercellotti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • JIM: Sickle Cell Disease with Dr. Gregory Vercellotti
    JIM: Sickle Cell Disease with Dr. Gregory VercellottiJanuary 27th, 2023
  • Sickle Cell Trait, Disease Linked with Faster Kidney Function Decline in African American Patients
    Sickle Cell Trait, Disease Linked with Faster Kidney Function Decline in African American PatientsFebruary 17th, 2020
  • University of Michigan Medical Student Earns Spot in 2019 ASH Minority Medical Student Award Program
    University of Michigan Medical Student Earns Spot in 2019 ASH Minority Medical Student Award ProgramSeptember 16th, 2019

Grant Support

  • Hematology Research Training ProgramUNIVERSITY OF MINNESOTA1982–2027
  • Heme Oxygenase 1 &StasisNational Heart, Lung, And Blood Institute2007–2011
  • Cell CultureNational Heart, Lung, And Blood Institute2007–2011
  • Inflammation In Sickle DiseaseNational Heart, Lung, And Blood Institute2001–2007
  • Core--Tissue CultureNational Heart, Lung, And Blood Institute1996–2002

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: